Compliance Lead
Vantive: A New Company Built On Our Legacy Baxter is on a journey to spin off our ~$5B Kidney Care segment into an independent, publicly traded company. Vantive* will build on our nearly 70-year legacy in acute therapies and home and in-center dialysis to provide best-in-class care to the people w...